Fredrik Bäckhed is granted SEK 43 million from Knut and Alice Wallenberg Foundation
MetaboGen founder Fredrik Bäckhed is granted SEK 43 million over five years for his project "Transforming microbiome research"
(...) Read the full storyNews
Latest news from Metabogen
MetaboGen at the 4th microbiome R&D and business collaboration forum in Amsterdam
MetaboGen is attending the 4th microbiome R&D and business collaboration forum & probiotics congress in Amsterdam on April 3-4.
Mee (...) Read the full story
Fredrik Bäckhed awarded Torsten Söderberg Professorship in Medicine
The Royal Swedish Academy of Sciences has awarded Fredrik Bäckhed the Torsten Söderberg Professorship in Medicine 2016 ”for his pione (...) Read the full story
Fredrik Bäckhed discusses the microbiome on Swedish TV
Fredrik Bäckhed explains how microbiome dysbiosis affects health in Swedish TV show.
To watch, follow the link!
MetaboGen Founder Jens Nielsen featured as one of the top 10 European scientist at Co-founding Biotechs
Read the article here:
http://labiotech.eu/10-european-scientist-best-co-founding-biotech-companies/
(...) Read the full storyMetaboGen at the Microbiome Drug Development Summit, Paris Jan 24-25
On January 24-26, MetaboGen will attend the 1st Microbiome Drug Development Summit Europe, taking place in Paris. Meet us there!
R (...) Read the full story
MetaboGen AB och Ferring Pharmaceuticals samarbetar i ett utvecklingsprojekt inom Intrahepatic Cholestasis of Pregnancy (ICP)
Göteborg, Sverige December 5, 2016 – MetaboGen AB (Göteborg, Sverige) och Ferring Pharmaceuticals (St-Prex, Schweiz) har ingått ett (...) Read the full story
MetaboGen receives third tranche of BioGaia investment
In December 2014, an investment agreement between MetaboGen AB and BioGaia AB was signed. The investment should be made over a two year p (...) Read the full story
Meet MetaboGen at Life Science-dagen 2016
Today, MetaboGen will take part in the Life Science-day 2016, at the Bonnier Conference Center in Stockholm. During the day, MetaboGen is (...) Read the full story
Welcome Charlotta!
Charlotta Movitz joins the MetaboGen team
(...) Read the full story